SWITZERLAND Trends and Developments
Trends and Developments Contributed by: Karim Maizar, Nicolas Mosimann, Alexandre Gachet and Nicolai Nuber Kellerhals Carrard
Kellerhals Carrard is a leading Swiss law firm serving clients from diverse sectors such as en - ergy and natural resources, financial services and insurance, industry and trade, public sector and procurement, healthcare and life sciences, and private equity. The firm is characterised by an interdisciplinary mindset, a strong team spir - it, and the dedication to provide optimum solu - tions tailored to its clients. It has a presence in all the language regions of Switzerland and a
strong international network. With a strong fo - cus on supporting start-ups and venture capital (VC), the Startup and VC Desk at Kellerhals Car - rard provides comprehensive legal advice for in - novative entrepreneurs in Switzerland. The team consists of experienced lawyers who specialise in the needs of start-ups and offer tailored solu - tions, and the firm is highly rated globally for its VC work in the country and region.
Authors
Karim Maizar is a partner at the Zurich office of Kellerhals Carrard, with a passion for start-ups. As co-founder and co-head of the firm’s Startup and VC Desk, he has led efforts
Nicolas Mosimann shares his clients’ passion for innovation, entrepreneurship and swift solutions to complex challenges. Nicolas co-heads the Kellerhals Carrard Start-up and Venture
to establish the firm as a leading Swiss law firm for entrepreneurs and their investors. Karim works with many of Switzerland’s most promising technology and life sciences start- ups at all stages of their growth. He also advises VCs, strategic investors, and business angels. His commitment to start-ups has earned him considerable recognition both within Switzerland and globally.
Capital Desk and the Life Sciences practice group and has in-depth experience with the start-up ecosystem and the entire life cycle of biotech, pharmaceutical, medtech and healthtech companies, including financing rounds, exits, listings, M&A transactions and licensing deals. As external general counsel of MoonLake Immunotherapeutics’ (Nasdaq: MLTX), Nicolas has gained a profound understanding of the needs of a biotech company and the life sciences industry.
556 CHAMBERS.COM
Powered by FlippingBook